𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of neoadjuvant biochemotherapy for stage III melanoma

✍ Scribed by Peter Gibbs; Clay Anderson; Nathan Pearlman; Stacy LaClaire; Maude Becker; Kristi Gatlin; Martin O'Driscoll; Janet Stephens; Rene Gonzalez

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
88 KB
Volume
94
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pilot study of high-dose, concurrent bio
Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma
✍ Kevin B. Kim; Omar Eton; Mary Jo East; Cynthia Hodges; Nicholas E. Papadopoulos; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Background: Durable complete response rates ranging from 5% to 20% have been reported in association with biochemotherapy for patients with metastatic melanoma, with response rates on the low end of this range being observed in trials that used lower doses and less intense treatment schedules. i